These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10702307)

  • 1. Epitope randomization redefines the functional role of glutamic acid 110 in interleukin-5 receptor activation.
    Wu SJ; Tambyraja R; Zhang W; Zahn S; Godillot AP; Chaiken I
    J Biol Chem; 2000 Mar; 275(10):7351-8. PubMed ID: 10702307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomization of the receptor alpha chain recruitment epitope reveals a functional interleukin-5 with charge depletion in the CD loop.
    Wu SJ; Li J; Tsui P; Cook R; Zhang W; Hu Y; Canziani G; Chaiken I
    J Biol Chem; 1999 Jul; 274(29):20479-88. PubMed ID: 10400676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation.
    Plugariu CG; Wu SJ; Zhang W; Chaiken I
    Biochemistry; 2000 Dec; 39(48):14939-49. PubMed ID: 11101310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2 and JAK1 constitutively associate with an interleukin-5 (IL-5) receptor alpha and betac subunit, respectively, and are activated upon IL-5 stimulation.
    Ogata N; Kouro T; Yamada A; Koike M; Hanai N; Ishikawa T; Takatsu K
    Blood; 1998 Apr; 91(7):2264-71. PubMed ID: 9516124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.
    Sato S; Katagiri T; Takaki S; Kikuchi Y; Hitoshi Y; Yonehara S; Tsukada S; Kitamura D; Watanabe T; Witte O; Takatsu K
    J Exp Med; 1994 Dec; 180(6):2101-11. PubMed ID: 7525847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling domains of the beta c chain of the GM-CSF/IL-3/IL-5 receptor.
    Okuda K; Foster R; Griffin JD
    Ann N Y Acad Sci; 1999 Apr; 872():305-12; discussion 312-3. PubMed ID: 10372132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structure and function of IL-5 receptor].
    Takatsu K
    Yakugaku Zasshi; 1995 Aug; 115(8):570-83. PubMed ID: 7473055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of critical residues in the cytoplasmic domain of the human interleukin-5 receptor alpha chain required for growth signal transduction.
    Cornelis S; Fache I; Van der Heyden J; Guisez Y; Tavernier J; Devos R; Fiers W; Plaetinck G
    Eur J Immunol; 1995 Jul; 25(7):1857-64. PubMed ID: 7542592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic peptide interleukin 5 antagonists mimic CD turn recognition epitope for receptor alpha.
    Ruchala P; Varadi G; Ishino T; Scibek J; Bhattacharya M; Urbina C; Ryk DV; Uings I; Chaiken I
    Biopolymers; 2004 Apr; 73(5):556-68. PubMed ID: 15048779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interleukin-5 receptor].
    Ogata N; Takatsu K
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():534-7. PubMed ID: 9172584
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and function of protein kinase B and MAP kinase activation by the IL-5/GM-CSF/IL-3 receptor.
    Dijkers PF; van Dijk TB; de Groot RP; Raaijmakers JA; Lammers JW; Koenderman L; Coffer PJ
    Oncogene; 1999 Jun; 18(22):3334-42. PubMed ID: 10362354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope-labeled soluble human interleukin-5 (IL-5) receptors. Affinity cross-link labeling, IL-5 binding, and biological activity.
    Brown PM; Tagari P; Rowan KR; Yu VL; O'Neill GP; Middaugh CR; Sanyal G; Ford-Hutchinson AW; Nicholson DW
    J Biol Chem; 1995 Dec; 270(49):29236-43. PubMed ID: 7493953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical proline residues of the cytoplasmic domain of the IL-5 receptor alpha chain and its function in IL-5-mediated activation of JAK kinase and STAT5.
    Kouro T; Kikuchi Y; Kanazawa H; Hirokawa K; Harada N; Shiiba M; Wakao H; Takaki S; Takatsu K
    Int Immunol; 1996 Feb; 8(2):237-45. PubMed ID: 8671609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
    Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
    J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of IL-5-mediated signal transduction, eosinophil survival, and inflammatory mediator release by a soluble human IL-5 receptor.
    Monahan J; Siegel N; Keith R; Caparon M; Christine L; Compton R; Cusik S; Hirsch J; Huynh M; Devine C; Polazzi J; Rangwala S; Tsai B; Portanova J
    J Immunol; 1997 Oct; 159(8):4024-34. PubMed ID: 9378992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical cytoplasmic domains of human interleukin-9 receptor alpha chain in interleukin-9-mediated cell proliferation and signal transduction.
    Zhu YX; Sun HB; Tsang ML; McMahel J; Grigsby S; Yin T; Yang YC
    J Biol Chem; 1997 Aug; 272(34):21334-40. PubMed ID: 9261146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of a cross-talk between IL-2 and IL-5 in phosphorylation of IL-2 and IL-5 receptor beta chains.
    Ohbo K; Asao H; Kouro T; Nakamura M; Takaki S; Kikuchi Y; Hirokawa K; Tominaga A; Takatsu K; Sugamura K
    Int Immunol; 1996 Jun; 8(6):951-60. PubMed ID: 8671684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single chain human interleukin 5 and its asymmetric mutagenesis for mapping receptor binding sites.
    Li J; Cook R; Dede K; Chaiken I
    J Biol Chem; 1996 Jan; 271(4):1817-20. PubMed ID: 8567620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.